Clinical Trials

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT04597125 2026-04-15

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

654 enrolled

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT04108208 2026-04-13

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

75 enrolled 9 charts

Prostatic Neoplasms

NCT02555748 2026-03-31

SUP-R

Phase 4 Completed

47 enrolled

Carcinoma, Renal Cell

NCT05348876 2026-03-19

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

50 enrolled

Prostatic Neoplasms

NCT07474519 2026-03-16

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

40 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

100 enrolled

Carcinoma, Transitional Cell

NCT03348969 2026-03-03

NICSA

Phase 4 Completed

120 enrolled

Urinary Bladder Neoplasms

NCT05700903 2026-03-02

ARCH

Phase 4 Completed

10 enrolled

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

100 enrolled

Phase 4 Not yet recruiting

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT07278362 2026-02-23

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

35 enrolled

Eunuchism, Prostatic Neoplasms

NCT06764095 2026-02-12

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

75 enrolled

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT06627530 2026-02-11

COAction

144 enrolled

Prostatic Neoplasms

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Suspended

600 enrolled

Prostatic Neoplasms

NCT07252726 2026-02-09

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

50 enrolled

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT06099093 2026-01-29

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

30 enrolled